Methyl 8-hydroxy-1,2-bis(4-hydroxy-3-methoxyphenyl)-9-methoxypyrrolo[2,1-a]isoquinoline-3-carboxylate
C29H25NO8 — CID 11526396
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 8-hydroxy-1,2-bis(4-hydroxy-3-methoxyphenyl)-9-methoxypyrrolo[2,1-a]isoquinoline-3-carboxylate
Methyl 8-hydroxy-1,2-bis(4-hydroxy-3-methoxyphenyl)-9-methoxypyrrolo[2,1-a]isoquinoline-3-carboxylate (PubChem CID 11526396) has the molecular formula C29H25NO8 and a molecular weight of 515.52 g/mol. Its IUPAC name is methyl 8-hydroxy-1,2-bis(4-hydroxy-3-methoxyphenyl)-9-methoxypyrrolo[2,1-a]isoquinoline-3-carboxylate.
Molecular Properties
| Compound Name | Methyl 8-hydroxy-1,2-bis(4-hydroxy-3-methoxyphenyl)-9-methoxypyrrolo[2,1-a]isoquinoline-3-carboxylate |
|---|---|
| PubChem CID | 11526396 |
| Molecular Formula | C29H25NO8 |
| Molecular Weight | 515.52 g/mol |
| Exact Mass | 515.16 |
| IUPAC Name | methyl 8-hydroxy-1,2-bis(4-hydroxy-3-methoxyphenyl)-9-methoxypyrrolo[2,1-a]isoquinoline-3-carboxylate |
| SMILES | COC(=O)c1c(-c2ccc(O)c(OC)c2)c(-c2ccc(O)c(OC)c2)c2c3cc(OC)c(O)cc3ccn12 |
| InChI | InChI=1S/C29H25NO8/c1-35-22-12-16(5-7-19(22)31)25-26(17-6-8-20(32)23(13-17)36-2)28(29(34)38-4)30-10-9-15-11-21(33)24(37-3)14-18(15)27(25)30/h5-14,31-33H,1-4H3 |
| InChIKey | GNMKOWGXNLPHHH-UHFFFAOYSA-N |
| XLogP | 5.36 |
| TPSA | 119.09 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 515.52 |
| LogP ≤ 5 | 5.36 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11526396 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.